Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL
Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
CMAC 2011
December 6-7, 2011 — Philadelphia, PA
Just Released: New Trends in Preventive and Therapeutic Vaccine

More Events >>

Related Tags >> Jennerex Onyx Pharmaceuticals

Nexavar News

Most Popular Nexavar Story

Engineered smallpox vaccine helps liver cancer patients

November 10, 2011 — 8:39am ET | By Maureen Martino

San Francisco-based Jennerex reported that liver cancer patients who received the high dose of the company's genetically engineered smallpox vaccine lived a median of 13.8 months versus just 6.7 Read more...

Nexavar Press Releases

In the United States, Nearly All Surveyed Physicians Prescribe Pfizer’s Sutent and a Significant Majority Prescribe Bayer/
Onyx Pharmaceuticals to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Onc
BioInvent and ThromboGenics Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Part
Ardea Biosciences to Present at Two Upcoming Investor Conferences

Latest Headlines

Engineered smallpox vaccine helps liver cancer patients
November 10, 2011

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK